NXTC
NextCure Inc
NASDAQ: NXTC · HEALTHCARE · BIOTECHNOLOGY
$9.21
+3.02% today
Updated 2026-04-30
Market cap
$34.70M
P/E ratio
—
P/S ratio
9.52x
EPS (TTM)
$-19.65
Dividend yield
—
52W range
$4 – $16
Volume
0.1M
NextCure Inc (NXTC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-83.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-97.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-2.0%
2026-03-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-06 | $-0.81 | +64.6% | $12.76 | $12.51 | -2.0% |
| 2025-11-05 | $-3.22 | -615.6% | $9.64 | $9.82 | +1.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-2.29 | $-0.81 | +64.6% | — | — |
| 2025-09-30 | $-0.45 | $-3.22 | -615.6% | — | — |
| 2025-06-30 | $-0.43 | $-11.29 | -2556.5% | — | — |
| 2025-03-31 | $-0.40 | $-0.39 | +2.5% | — | — |
| 2024-12-31 | $-0.36 | $-0.41 | -13.9% | $3.28M | -47.8% |
| 2024-09-30 | $-0.34 | $-0.41 | -20.6% | — | — |
| 2024-06-30 | $-0.38 | $-0.55 | -44.7% | — | — |
| 2024-03-31 | $-0.46 | $-0.61 | -32.6% | — | — |
| 2023-12-31 | $-0.54 | $-0.52 | +3.7% | $6.28M | — |
| 2023-09-30 | $-0.66 | $-0.51 | +22.7% | — | — |
| 2023-06-30 | $-0.59 | $-0.64 | -8.5% | — | — |
| 2023-03-31 | $-0.64 | $-0.58 | +9.4% | — | — |
Frequently asked questions
Has NextCure Inc beaten earnings estimates?
NextCure Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -83.2% over the last 4 quarters.
How does NXTC stock react to earnings?
NXTC stock has moved an average of -0.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.